Thrombectomy Device Open Frame Cell Ring Clot Engagement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing stent retriever devices for mechanical thrombectomy suffer from suboptimal clot engagement, retention, and vessel interaction due to their unitary stent body design, which can roll over and fail to capture hard clots, and may apply excessive radial force to the vessel.

Innovation Solution

A mechanical thrombectomy device featuring a support wire with independently mounted clot arrestors, each with frame cell rings of varying radial strength and open/closed configurations, allowing for effective clot engagement and retention while minimizing vessel contact.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If a unitary stent body is used to provide radial strength for clot engagement, then clot capture capability is improved, but the device may roll over and bounce off hard clots, reducing engagement effectiveness

Engineering Contradiction:
Improveradial strengthVSAvoidclot engagement reliability
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The stent body is divided into multiple segments or modules that can independently engage the clot. Instead of a single unitary structure, the stent comprises multiple radial elements that can flex and adapt to engage hard clots without rolling over, improving both radial strength and engagement reliability

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The stent design incorporates dynamic elements that allow the radial strength to adapt during deployment. The stent can transition from a compressed state to an expanded state with varying radial profiles, enabling it to engage clots of different hardness and maintain contact without bouncing off

Inventive Principle:
Principle #15Dynamics

2Strength

If the stent fully apposes the vessel to achieve sufficient radial strength for clot engagement, then clot capture is improved, but the risk of vessel injury increases

Engineering Contradiction:
Improveradial strengthVSAvoidvessel injury risk
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The stent applies radial strength locally at specific engagement zones rather than uniformly across the entire vessel circumference. This allows sufficient radial force to engage the clot while leaving other portions of the vessel wall unapposed, reducing overall vessel injury risk

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The stent applies partial apposition to the vessel wall, providing just enough radial strength to engage the clot without full circumferential contact. This partial action achieves the necessary clot capture while minimizing excessive force that could injure the vessel

Inventive Principle:
Principle #16Partial or excessive action

3Device complexity

If a unitary stent body is used to simplify device structure, then device complexity is reduced, but clot capture and engagement capability deteriorates

Engineering Contradiction:
Improvestent structure complexityVSAvoidclot capture capability
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The stent is segmented into multiple functional elements that can independently interact with the clot. This segmentation provides multiple engagement points and mechanisms, improving clot capture capability while maintaining a relatively simple overall device structure through modular design

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The stent employs a nested structure where smaller functional elements are contained within or between larger structural components. This nesting approach allows complex clot engagement functionality to be achieved within a compact and relatively simple device architecture

Inventive Principle:
Principle #7Nested doll (Nesting)

Data Source

PatentUS20250040949A1Thrombectomy device having open frame cell ring
Publication Date: 2025.02.06 NVENTRIC CORP
  • US20250040949A1 patent drawing
  • US20250040949A1 patent drawing
  • US20250040949A1 patent drawing

AI summary

A mechanical thrombectomy device includes several clot arrestors mounted on a support wire. The clot arrestors have rings of expandable frame cells. The frame cell rings include an open frame cell ring, having a gap between adjacent frame cells in the ring, and a closed frame cell ring, having no gap between adjacent frame cells. The gap allows clots to enter the clot arrestor for retrieval from a target anatomy. Other embodiments are also described and claimed.